Total Funding
53
33
Total FundingPost-IPO Equity raised
Growth Score
-13 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
29090
Dizal Pharma is a biotechnology company that conducts research for the treatment of cancer and immunological diseases.
- Xiaolin Zhang: Chief Executive Officer & Founder
- Hongbin Lyu: Chief Financial Officer
About the Company
Dizal Pharmaceutical is a research-based biotechnology company dedicated to the discovery, development, and commercialization of first-in-class/best-in-class medicines.
